5.25
Applied Dna Sciences Inc Aktie (APDN) Neueste Nachrichten
Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application - Cincinnati Enquirer
Applied DNA receives $600,000 follow-on order for LineaDNA product By Investing.com - Investing.com UK
Applied DNA Lands 7th Major Order as Global Cancer Diagnostic Maker Expands LineaDNA Usage - Stock Titan
What analysts say about Applied DNA Sciences Inc. stockGame-changing capital returns - jammulinksnews.com
Applied DNA Sciences Inc. Stock Analysis and ForecastHigh-performance investment picks - Autocar Professional
Is Applied DNA Sciences Inc. a good long term investmentOutperformance with explosive growth - jammulinksnews.com
What drives Applied DNA Sciences Inc. stock priceOutstanding capital growth - jammulinksnews.com
Is Applied DNA Sciences Inc. stock a good hedge against inflationCapital Doubling Tips - Newser
Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements - Sentinel-Standard
Why Applied DNA Sciences Inc. stock attracts strong analyst attentionValue Pick Scanner - Newser
How Applied DNA Sciences Inc. stock performs during market volatilityPredictable High Return Trades - Newser
What makes Applied DNA Sciences Inc. stock price move sharplyDouble Your Capital Alerts - Newser
Stem Down -7.5% to $8.62 - AInvest
Applied DNA Sciences Regains Nasdaq Compliance - The Globe and Mail
Applied DNA Sciences regains Nasdaq compliance with $1 minimum bid By Investing.com - Investing.com Nigeria
Applied DNA Sciences regains Nasdaq compliance, scheduled hearing cancelled - Investing.com
Applied DNA Sciences regains Nasdaq compliance with $1 minimum bid - Investing.com
Applied DNA Just Cleared Critical $1 Nasdaq Requirement: Delisting Risk Eliminated - Stock Titan
Applied DNA Sciences regains Nasdaq compliance, scheduled hearing cancelled By Investing.com - Investing.com Nigeria
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx - Marco Eagle
Applied DNA Sciences Announces Strategic Restructuring - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):